CN Patent

CN113372358A — 噻吩并嘧啶衍生物的制备方法

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2021-09-10 · 5y expired

What this patent protects

本发明提供了高产率地制备高品质的噻吩并嘧啶衍生物或其盐的方法，所述噻吩并嘧啶衍生物或其盐具有促性腺素释放激素(GnRH)拮抗作用。本发明提供了制备噻吩并嘧啶衍生物的方法，所述方法包括：将6‑(4‑氨基苯基)‑1‑(2,6‑二氟苄基)‑5‑二甲基氨基甲基‑3‑(6‑甲氧基哒嗪‑3‑基)噻吩并[2,3‑d]嘧啶‑2,4(1H,3H)‑二酮或其盐、1,1'‑羰基二咪唑或其盐和甲氧基胺或其盐进行反应，等等。

USPTO Abstract

本发明提供了高产率地制备高品质的噻吩并嘧啶衍生物或其盐的方法，所述噻吩并嘧啶衍生物或其盐具有促性腺素释放激素(GnRH)拮抗作用。本发明提供了制备噻吩并嘧啶衍生物的方法，所述方法包括：将6‑(4‑氨基苯基)‑1‑(2,6‑二氟苄基)‑5‑二甲基氨基甲基‑3‑(6‑甲氧基哒嗪‑3‑基)噻吩并[2,3‑d]嘧啶‑2,4(1H,3H)‑二酮或其盐、1,1'‑羰基二咪唑或其盐和甲氧基胺或其盐进行反应，等等。

Drugs covered by this patent

Patent Metadata

Patent number
CN113372358A
Jurisdiction
CN
Classification
—
Expires
2021-09-10
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.